(Q41642751)

6 October 2017

1 reference

title

Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone (English)

1 reference

adaptive radiation therapy

6 October 2017

main subject

0 references

author name string

Prosnitz LR

series ordinal

1

1 reference

6 October 2017

Brizel DM

series ordinal

2

1 reference

6 October 2017

Light KL

series ordinal

3

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

International Journal of Radiation Oncology Biology Physics

6 October 2017

published in

1 reference

6 October 2017

volume

39

1 reference

6 October 2017

issue

4

1 reference

6 October 2017

page(s)

885-895

1 reference

Adjuvant treatment in the curative management of rectal cancer: a critical review of the results of clinical randomised trials

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

A re-analysis of available dose-response and time-dose data in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Improved survival in advanced Hodgkin's disease with the use of combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Second solid malignancies after combined modality therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Cure of Hodgkin's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Theoretical considerations in combinations of localized and systemic therapy for neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Dosimetry of Hodgkin's disease therapy using a 4 MV linear accelerator

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Patterns of care outcome studies. Results of the national practice in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Reduction of treatment for early stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

The clinical course of Hodgkin's disease and other malignant lymphomas treated with radical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

The case for adjuvant radiation therapy in advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Prognostic factors in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Hodgkin's disease, stages I and II.Relationship of recurrence to size of disease, radiation dose, and number of sites involved

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

An updated dose-response analysis in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

The Role of Adjuvant Radiation Therapy for Stages III and IV Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900463-X

7 January 2021

10.1016/S0360-3016(97)00463-X

Identifiers

DOI

1 reference

6 October 2017

1 reference